Copyright Reports & Markets. All rights reserved.

Global Corticosteroid Medication Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Corticosteroid Medication
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Corticosteroid Medication Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Tablets
    • 1.3.3 Capsules
    • 1.3.4 Eye Drops
    • 1.3.5 Lotions, Creams, Ointments, or Gels
    • 1.3.6 Nasal or Mouth Sprays
    • 1.3.7 Injections
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Corticosteroid Medication Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Pharmacy
  • 1.5 Global Corticosteroid Medication Market Size & Forecast
    • 1.5.1 Global Corticosteroid Medication Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Corticosteroid Medication Sales Quantity (2018-2029)
    • 1.5.3 Global Corticosteroid Medication Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sumitomo
    • 2.1.1 Sumitomo Details
    • 2.1.2 Sumitomo Major Business
    • 2.1.3 Sumitomo Corticosteroid Medication Product and Services
    • 2.1.4 Sumitomo Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sumitomo Recent Developments/Updates
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Corticosteroid Medication Product and Services
    • 2.2.4 Pfizer Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Pfizer Recent Developments/Updates
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Corticosteroid Medication Product and Services
    • 2.3.4 Novartis Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novartis Recent Developments/Updates
  • 2.4 Merck
    • 2.4.1 Merck Details
    • 2.4.2 Merck Major Business
    • 2.4.3 Merck Corticosteroid Medication Product and Services
    • 2.4.4 Merck Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Merck Recent Developments/Updates
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi Corticosteroid Medication Product and Services
    • 2.5.4 Sanofi Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Sanofi Recent Developments/Updates
  • 2.6 Johnson & Johnson
    • 2.6.1 Johnson & Johnson Details
    • 2.6.2 Johnson & Johnson Major Business
    • 2.6.3 Johnson & Johnson Corticosteroid Medication Product and Services
    • 2.6.4 Johnson & Johnson Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Johnson & Johnson Recent Developments/Updates
  • 2.7 GSK
    • 2.7.1 GSK Details
    • 2.7.2 GSK Major Business
    • 2.7.3 GSK Corticosteroid Medication Product and Services
    • 2.7.4 GSK Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 GSK Recent Developments/Updates
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Corticosteroid Medication Product and Services
    • 2.8.4 AstraZeneca Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 AstraZeneca Recent Developments/Updates
  • 2.9 Cipla
    • 2.9.1 Cipla Details
    • 2.9.2 Cipla Major Business
    • 2.9.3 Cipla Corticosteroid Medication Product and Services
    • 2.9.4 Cipla Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Cipla Recent Developments/Updates
  • 2.10 LEO Pharma
    • 2.10.1 LEO Pharma Details
    • 2.10.2 LEO Pharma Major Business
    • 2.10.3 LEO Pharma Corticosteroid Medication Product and Services
    • 2.10.4 LEO Pharma Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 LEO Pharma Recent Developments/Updates
  • 2.11 Abbott Laboratories
    • 2.11.1 Abbott Laboratories Details
    • 2.11.2 Abbott Laboratories Major Business
    • 2.11.3 Abbott Laboratories Corticosteroid Medication Product and Services
    • 2.11.4 Abbott Laboratories Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Abbott Laboratories Recent Developments/Updates
  • 2.12 Bayer
    • 2.12.1 Bayer Details
    • 2.12.2 Bayer Major Business
    • 2.12.3 Bayer Corticosteroid Medication Product and Services
    • 2.12.4 Bayer Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Bayer Recent Developments/Updates
  • 2.13 Tianjin Tianyao Pharmaceuticals Co., Ltd.
    • 2.13.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Details
    • 2.13.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Major Business
    • 2.13.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product and Services
    • 2.13.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates
  • 2.14 Zhejiang Xianju Pharmaceutical Co.,Ltd
    • 2.14.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Details
    • 2.14.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
    • 2.14.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product and Services
    • 2.14.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
  • 2.15 Shandong Xinhua Pharmaceutical Company Limited
    • 2.15.1 Shandong Xinhua Pharmaceutical Company Limited Details
    • 2.15.2 Shandong Xinhua Pharmaceutical Company Limited Major Business
    • 2.15.3 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product and Services
    • 2.15.4 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
  • 2.16 Yangzi River Pharmaceutical Group
    • 2.16.1 Yangzi River Pharmaceutical Group Details
    • 2.16.2 Yangzi River Pharmaceutical Group Major Business
    • 2.16.3 Yangzi River Pharmaceutical Group Corticosteroid Medication Product and Services
    • 2.16.4 Yangzi River Pharmaceutical Group Corticosteroid Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Yangzi River Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Corticosteroid Medication by Manufacturer

  • 3.1 Global Corticosteroid Medication Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Corticosteroid Medication Revenue by Manufacturer (2018-2023)
  • 3.3 Global Corticosteroid Medication Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Corticosteroid Medication by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Corticosteroid Medication Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Corticosteroid Medication Manufacturer Market Share in 2022
  • 3.5 Corticosteroid Medication Market: Overall Company Footprint Analysis
    • 3.5.1 Corticosteroid Medication Market: Region Footprint
    • 3.5.2 Corticosteroid Medication Market: Company Product Type Footprint
    • 3.5.3 Corticosteroid Medication Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Corticosteroid Medication Market Size by Region
    • 4.1.1 Global Corticosteroid Medication Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Corticosteroid Medication Consumption Value by Region (2018-2029)
    • 4.1.3 Global Corticosteroid Medication Average Price by Region (2018-2029)
  • 4.2 North America Corticosteroid Medication Consumption Value (2018-2029)
  • 4.3 Europe Corticosteroid Medication Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Corticosteroid Medication Consumption Value (2018-2029)
  • 4.5 South America Corticosteroid Medication Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Corticosteroid Medication Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Corticosteroid Medication Sales Quantity by Type (2018-2029)
  • 5.2 Global Corticosteroid Medication Consumption Value by Type (2018-2029)
  • 5.3 Global Corticosteroid Medication Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Corticosteroid Medication Sales Quantity by Application (2018-2029)
  • 6.2 Global Corticosteroid Medication Consumption Value by Application (2018-2029)
  • 6.3 Global Corticosteroid Medication Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Corticosteroid Medication Sales Quantity by Type (2018-2029)
  • 7.2 North America Corticosteroid Medication Sales Quantity by Application (2018-2029)
  • 7.3 North America Corticosteroid Medication Market Size by Country
    • 7.3.1 North America Corticosteroid Medication Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Corticosteroid Medication Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Corticosteroid Medication Sales Quantity by Type (2018-2029)
  • 8.2 Europe Corticosteroid Medication Sales Quantity by Application (2018-2029)
  • 8.3 Europe Corticosteroid Medication Market Size by Country
    • 8.3.1 Europe Corticosteroid Medication Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Corticosteroid Medication Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Corticosteroid Medication Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Corticosteroid Medication Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Corticosteroid Medication Market Size by Region
    • 9.3.1 Asia-Pacific Corticosteroid Medication Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Corticosteroid Medication Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Corticosteroid Medication Sales Quantity by Type (2018-2029)
  • 10.2 South America Corticosteroid Medication Sales Quantity by Application (2018-2029)
  • 10.3 South America Corticosteroid Medication Market Size by Country
    • 10.3.1 South America Corticosteroid Medication Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Corticosteroid Medication Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Corticosteroid Medication Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Corticosteroid Medication Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Corticosteroid Medication Market Size by Country
    • 11.3.1 Middle East & Africa Corticosteroid Medication Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Corticosteroid Medication Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Corticosteroid Medication Market Drivers
  • 12.2 Corticosteroid Medication Market Restraints
  • 12.3 Corticosteroid Medication Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Corticosteroid Medication and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Corticosteroid Medication
  • 13.3 Corticosteroid Medication Production Process
  • 13.4 Corticosteroid Medication Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Corticosteroid Medication Typical Distributors
  • 14.3 Corticosteroid Medication Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Corticosteroid Medication market size was valued at USD 4990.4 million in 2022 and is forecast to a readjusted size of USD 6833.9 million by 2029 with a CAGR of 4.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Corticosteroids are synthetic analogs of the natural steroid hormones produced by the adrenal cortex and include glucocorticoids and mineralocorticoids. The synthetic hormones have varying degrees of glucocorticoid and mineralocorticoid properties. Glucocorticoids are predominantly involved in metabolism and have immunosuppressive, anti-inflammatory, and vasoconstrictive effects. Corticosteroid drugs (including cortisone, hydrocortisone and prednisone) are useful in treating many conditions, such as rashes, inflammatory bowel disease and asthma.
    This report is a detailed and comprehensive analysis for global Corticosteroid Medication market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Corticosteroid Medication market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Corticosteroid Medication market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Corticosteroid Medication market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Corticosteroid Medication market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Corticosteroid Medication
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Corticosteroid Medication market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sumitomo, Pfizer, Novartis, Merck and Sanofi, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Corticosteroid Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Tablets
    Capsules
    Eye Drops
    Lotions, Creams, Ointments, or Gels
    Nasal or Mouth Sprays
    Injections
    Market segment by Application
    Hospital
    Clinic
    Pharmacy
    Major players covered
    Sumitomo
    Pfizer
    Novartis
    Merck
    Sanofi
    Johnson & Johnson
    GSK
    AstraZeneca
    Cipla
    LEO Pharma
    Abbott Laboratories
    Bayer
    Tianjin Tianyao Pharmaceuticals Co., Ltd.
    Zhejiang Xianju Pharmaceutical Co.,Ltd
    Shandong Xinhua Pharmaceutical Company Limited
    Yangzi River Pharmaceutical Group
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Corticosteroid Medication product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Corticosteroid Medication, with price, sales, revenue and global market share of Corticosteroid Medication from 2018 to 2023.
    Chapter 3, the Corticosteroid Medication competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Corticosteroid Medication breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Corticosteroid Medication market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Corticosteroid Medication.
    Chapter 14 and 15, to describe Corticosteroid Medication sales channel, distributors, customers, research findings and conclusion.

    Buy now